Actos litigation
Litigation linked long-term use of the diabetes drug Actos to an increased risk of bladder cancer.
Free case review
What the litigation alleged
Studies associated pioglitazone (Actos) taken for more than a year with an elevated risk of bladder cancer, and regulators in several countries restricted or suspended the drug. The United States litigation, which produced one of the larger pharmaceutical settlements of its era, alleged the manufacturer downplayed that risk for years.
While the original settlement program has closed, people with recent diagnoses after long-term Actos use can still ask us to evaluate their circumstances.
Injuries named in the litigation
- Bladder cancer
- Recurrent bladder tumors
- Bladder removal (cystectomy)
Who may qualify
If you took Actos for an extended period and were diagnosed with bladder cancer, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.